Biovie (BIVI) Net Shares Issued and Repurchased (2021 - 2026)

Biovie has disclosed Net Shares Issued and Repurchased across 6 years of filings, most recently posting $1500.0 for Q2 2026.

• In Q2 2026, Net Shares Issued and Repurchased fell 91.27% year-over-year to $1500.0; the TTM figure through Jun 2026 stood at $1500.0 (down 91.27% YoY), while the FY2026 annual figure was $1500.0, down 91.27% from the prior year.
• Net Shares Issued and Repurchased came in at $1500.0 for Q2 2026 at Biovie, down from $17190.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $2.7 million in Q2 2022 to a low of $80.0 in Q3 2024.
• Average Net Shares Issued and Repurchased over 5 years is $406882.4, with a median of $17190.0 recorded in 2025.
• Year-over-year, Net Shares Issued and Repurchased surged 290.36% in 2022 and plunged 97.48% in 2023.
• Over 5 years, Net Shares Issued and Repurchased stood at $25600.0 in 2022, then soared by 168.4% to $68711.0 in 2023, then tumbled by 99.88% to $80.0 in 2024, then soared by 21387.5% to $17190.0 in 2025, then plunged by 91.27% to $1500.0 in 2026.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $1500.0 in Q2 2026, $17190.0 in Q2 2025, and $80.0 in Q3 2024.